Core Viewpoint - Cigna Group reported strong second-quarter 2025 results with adjusted EPS of $7.20, exceeding estimates and showing a year-over-year increase of 7.1% alongside adjusted revenues of $67.1 billion, which rose 11% year over year [1][10]. Financial Performance - Adjusted revenues of $67.1 billion surpassed the consensus estimate by 7.1% [1] - Total benefits and expenses increased 12% year over year to $64.9 billion, driven by higher pharmacy and service costs [4] - Adjusted income from operations was $1.9 billion, a 1% increase year over year [4] Segment Performance - Evernorth Health Services segment achieved adjusted revenues of $57.8 billion, up 17% year over year, benefiting from new business and improved specialty volumes [5] - Cigna Healthcare segment's adjusted revenues fell 18% year over year to $10.8 billion, impacted by divestitures, but still slightly beat estimates [7] - Medical customer base decreased by 5.2% year over year to 18 million, although it exceeded the consensus estimate [3][10] Expense and Margin Analysis - Adjusted SG&A expense ratio improved by 110 basis points year over year to 4.9% due to a favorable business mix [4] - Adjusted pre-tax operating income for Evernorth rose 5% year over year to $1.7 billion, while the adjusted pre-tax margin declined by 40 basis points to 2.9% [6] Financial Position - Cash and cash equivalents decreased by 42.7% from the end of 2024 to $4.3 billion [11] - Total assets fell 2.7% to $151.7 billion, while long-term debt decreased by 8.5% to $26.5 billion [11] Capital Deployment - Cigna repurchased shares worth approximately $2.6 billion in the first half of 2025 [13] 2025 Outlook - Adjusted EPS is projected to be a minimum of $29.60, indicating at least 8.3% growth from 2024 [14] - Adjusted revenues are expected to reach a minimum of $252 billion, reflecting at least a 2% increase from 2024 [15]

BLOOMFIELD, Conn., July 31, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong second quarter 2025 results, reflecting continued growth and solid performance across its diverse portfolio of businesses. "Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients enables us to deliver meaningful value," said David M. Cordani, chairman and CEO of The Cigna Group. "Our performance in the second quarter reflects our disciplined ...

Core Insights - Cigna Group reported first-quarter 2025 revenue of $65.45 billion, exceeding analyst estimates of $60.39 billion, with a year-over-year sales increase of 14% driven by existing client relationships and strong growth in specialty pharmacy services [1] - Adjusted earnings per share were $6.74, surpassing analysts' expectations of $6.35 [1] Revenue Breakdown - Evernorth Health Services, which includes Pharmacy Benefit and Specialty and Care Services, achieved first-quarter sales of $53.68 billion, reflecting a 16% increase [2] - Cigna Healthcare segment sales rose 9% to $14.48 billion, primarily due to premium rate increases to cover expected medical cost increases [3] Customer Metrics - Total medical customers decreased by 6% from December 31, 2024, to 18.04 million, largely due to the impact of the HCSC transaction; however, excluding this impact, customer numbers remained stable [4] - Total customer relationships reached 182.2 million as of March 31, 2025, with a 1% increase when excluding the HCSC transaction [4] - Total pharmacy customers increased by 3% to 122.3 million, attributed to new sales and expanded relationships [4] Future Outlook - Cigna anticipates fiscal 2025 adjusted income per share of $29.60, slightly up from the previous estimate of $29.50, aligning with consensus expectations [5] - Evernorth's adjusted income from operations is projected to be at least $7.2 billion, with Cigna Healthcare expected to contribute at least $4.125 billion [5] Financial Ratios - The Cigna Healthcare Medical Care Ratio (MCR) is expected to range between 83.2% to 84.2% [6] - The MCR for the first quarter of 2025 was reported at 82.2%, an increase from 79.9% a year ago, primarily due to higher stop-loss medical costs [7]

Core Insights - The Cigna Group reported strong first quarter 2025 results, with significant growth across its diversified business portfolio, leading to an increased outlook for full-year earnings [1][2][20] Financial Performance - Shareholders' net income for Q1 2025 was $1.3 billion, or $4.85 per share, compared to a net loss of $0.3 billion, or $0.97 per share, in Q1 2024 [2][7] - Adjusted income from operations for Q1 2025 was $1.8 billion, or $6.74 per share, slightly down from $1.9 billion, or $6.47 per share, in Q1 2024 [3][7] - Total revenues for Q1 2025 increased by 14% to $65.5 billion compared to Q1 2024, driven by growth in existing client relationships and specialty pharmacy services [4][7] Customer Relationships - Total customer relationships as of March 31, 2025, were 182.2 million, reflecting a 1% increase excluding the impact of the HCSC transaction [15] - Total pharmacy customers increased by 3% to 122.3 million, while total medical customers decreased by 6% to 18.0 million, primarily due to the HCSC transaction [15][6] Segment Performance - Evernorth Health Services reported adjusted revenues of $53.7 billion for Q1 2025, with a 16% increase in adjusted income from operations, pre-tax [16] - Cigna Healthcare's adjusted income from operations, pre-tax, was $1.3 billion for Q1 2025, reflecting a slight decrease from the previous year [37] Outlook - The Cigna Group's outlook for full-year 2025 adjusted income from operations is projected to be at least $29.60 per share, an increase of $0.10 from prior projections [20][21]